Researchers have developed a new class of synthetic antibiotics known as macrolones, which are highly effective against bacterial resistance.
About Macrolones:
- Macrolones are synthetic antibiotics that merge the structures and mechanisms of two existing antibiotic types: macrolides and fluoroquinolones.
- Macrolides (e.g., erythromycin) obstruct the ribosome, the cellular factory responsible for protein production.
- Fluoroquinolones (e.g., ciprofloxacin) target a specific bacterial enzyme, DNA gyrase, crucial for DNA function.
- These antibiotics operate in two distinct manners: halting protein production or damaging the DNA structure. This dual action makes it exceedingly difficult for bacteria to develop resistance, as they must adapt to both mechanisms simultaneously.
- According to research from the University of Illinois Chicago, the introduction of macrolones makes it 100 million times more challenging for bacteria to evolve resistance compared to traditional antibiotics. This significantly enhances their effectiveness in combating infectious diseases.
Ref: Source
| UPSC IAS Preparation Resources | |
| Current Affairs Analysis | Topperspedia |
| GS Shots | Simply Explained |
| Daily Flash Cards | Daily Quiz |
Frequently Asked Questions (FAQs)
What are macrolones and how do they work?
Macrolones are synthetic antibiotics that combine macrolides and fluoroquinolones, targeting the ribosome and DNA gyrase to halt protein production and damage DNA structure. This dual action makes it difficult for bacteria to develop resistance.
How do macrolones differ from traditional antibiotics?
Macrolones have a dual action mechanism, targeting both ribosome and DNA gyrase, making it exceedingly difficult for bacteria to develop resistance. Traditional antibiotics typically only target one specific aspect of bacterial function, allowing bacteria to adapt more easily.
Why are macrolones considered more effective against infectious diseases?
Research from the University of Illinois Chicago shows that the introduction of macrolones makes it 100 million times more challenging for bacteria to evolve resistance compared to traditional antibiotics. This significantly enhances their effectiveness in combating infectious diseases.